| Price | 8.55 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $0.00 |
| Previous Close | $8.55 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $5.42 - $9.98 |
| Volume | 0 |
| Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes. | |





Comments: 0 | Comment
Comments: 2 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
buy. Has 2 Blockbuster drugs in the Pipeline, one for Endometriosis and the 2nd one is for DM II, hello...already has them sold off!
Comments: 0 | Comment
Comments: 0 | Comment